Kanebo skin-whitening product users report serious symptoms

Kanebo skin-whitening product users report serious symptoms

TOKYO, Japan - Masumi Natsusaka, president of Kanebo Cosmetics Inc., bows in a gesture of apology during a news conference in Tokyo on July 23, 2013. The company said that 2,250 users of its skin-whitening cosmetics have reported developing serious symptoms such as white blotches on their skin since it began a recall of 54 products on July 4.

  • Product Code
  • ILEA001185091
  • Registered date
  • 2013/7/23 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2013 Kyodo News
  • Media size
  • 2334 × 3828 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 977.10(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Takeda chief apologizes over data misuse in drug ad

    Takeda chief apologizes over data misuse in drug ad

    TOKYO, Japan - Takeda Pharmaceutical Co. President Yasuchika Hasegawa apologizes during a press conference in Tokyo on March 3, 2014, over an advertisement for the company's blood pressure-lowering drug that made it appear the product is more powerful in suppressing diseases than other medicines.
      Takeda chief apologizes over data misuse in drug ad

      Takeda chief apologizes over data misuse in drug ad

      TOKYO, Japan - Takeda Pharmaceutical Co. President Yasuchika Hasegawa apologizes during a press conference in Tokyo on March 3, 2014, over an advertisement for the company's blood pressure-lowering drug that made it appear the product is more powerful in suppressing diseases than other medicines.
        Novartis scandal

        Novartis scandal

        TOKYO, Japan - David Epstein (C), division head at Novartis AG, the Swiss-based pharmaceutical giant, and Yoshiyasu Ninomiya (R), president of Novartis Pharma K.K., a Japanese unit of Novartis AG, bow in apology during a press conference in Tokyo on Oct. 3, 2013. Novartis Pharma K.K. has allegedly engaged in deceptive advertizing for the blood pressure-lowering drug Diovan by citing a study based on manipulated clinical data.
          Novartis Pharma

          Novartis Pharma

          TOKYO, Japan - Yoshiyasu Ninomiya, president of Novartis Pharma K.K., attends a press conference in Tokyo on July 29, 2013. Novartis Pharma, a Japanese unit of Swiss drug company Novartis AG, said it has found no evidence a former employee manipulated or altered clinical research data for the drugmaker's Diovan blood pressure lowering drug.
            Kanebo skin-whitening product users report serious symptoms

            Kanebo skin-whitening product users report serious symptoms

            TOKYO, Japan - Masumi Natsusaka, president of Kanebo Cosmetics Inc., speaks at a news conference in Tokyo on July 23, 2013. The company said that 2,250 users of its skin-whitening cosmetics have reported developing serious symptoms such as white blotches on their skin since it began a recall of 54 products on July 4.
              Kanebo skin-whitening product users report serious symptoms

              Kanebo skin-whitening product users report serious symptoms

              TOKYO, Japan - Masumi Natsusaka, president of Kanebo Cosmetics Inc., holds a news conference in Tokyo on July 23, 2013. The company said that 2,250 users of its skin-whitening cosmetics have reported developing serious symptoms such as white blotches on their skin since it began a recall of 54 products on July 4.
                Data altered in Japanese research for Novartis blood pressure drug

                Data altered in Japanese research for Novartis blood pressure drug

                TOKYO, Japan - Toshikazu Yoshikawa (2nd from L), president of the Kyoto Prefectural University of Medicine, and Shinji Fushiki (L), the university窶冱 vice president, bow toward the end of a press conference in Kyoto on July 11, 2013. Yoshikawa apologized as the university found that data employed in a clinical study on Novartis Pharama K.K.'s blockbuster blood pressure lowering drug Diovan were manipulated.
                  Replica hearts

                  Replica hearts

                  OSAKA, Japan - The National Cerebral and Cardiovascular Center and product sample maker crossEffect Inc. unveil precise replicas of human hearts made of soft plastic in Suita, Osaka Prefecture, on July 2, 2013. They have jointly developed the heart models for use by surgeons to explain operations to patients and young doctors to practice procedures.
                    Replica hearts

                    Replica hearts

                    OSAKA, Japan - The National Cerebral and Cardiovascular Center and product sample maker crossEffect Inc. unveil precise replicas of human hearts made of soft plastic in Suita, Osaka Prefecture, on July 2, 2013. They have jointly developed the heart models for use by surgeons to explain operations to patients and young doctors to practice procedures.
                      Artificial spider silk

                      Artificial spider silk

                      TOKYO, Japan - Kazuhide Sekiyama, president of bioventure Spiber Inc., stands in Tokyo on May 24, 2013, by a dress made by his company on a trial basis from artificially produced spider silk. The company based in Tsuruoka in Yamagata Prefecture, northeastern Japan, said it has developed technology to mass-produce artificial spider silk for the first time.